Fig. 2From: Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials Cumulative incidence of different outcomes in PARAGON-HF participants with diabetes. A New use of insulin. B New use of non-insulin antihyperglycemic medications. C Hypoglycemia. HR hazard ratio, CI confidence intervalBack to article page